Biogen on Wednesday forecast 2025 profit below last year's levels and Wall Street expectations on Wednesday, hit by a strong dollar and a sharp drop in sales as its multiple sclerosis drugs ...
Jan 27 (Reuters) - Sage Therapeutics (SAGE.O), opens new tab said on Monday that its board has unanimously rejected Biogen’s (BIIB.O), opens new tab $469 million offer, stating it "significantly ...